CentralReach Launches New Awards Program Recognizing Top Leaders Transforming Autism and IDD Care
26 juil. 2022 10h55 HE
|
CentralReach
Fort Lauderdale, FL, July 26, 2022 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD Care software, today announced the launch of the Autism and IDD Care Awards, the...
Hopebridge Expands Clinical Excellence Through New Role Supporting BCBAs
11 juil. 2022 07h00 HE
|
Hopebridge
Indianapolis, IN, July 11, 2022 (GLOBE NEWSWIRE) -- Hopebridge Autism Therapy Centers recently furthered its commitment to expand access to quality, value-based services for children with autism...
SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome
08 juil. 2022 08h30 HE
|
SciSparc Ltd
TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
SciSparc's JV MitoCareX Bio Launches its Advanced New Laboratory Facility
07 juil. 2022 08h30 HE
|
SciSparc Ltd
The new facility will serve the JV’s development of potential cancer drugs TEL AVIV, Israel, July 07, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a...
Little Leaves Behavioral Services Earns Three-Year Reaccreditation From Behavioral Health Center of Excellence
06 juil. 2022 10h26 HE
|
Little Leaves
SILVER SPRING, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based Applied Behavioral Analysis (ABA) for children, today announced it has...
SciSparc Board of Directors to Promote Buyback Program of up to $1 Million
06 juil. 2022 08h30 HE
|
SciSparc Ltd
TEL AVIV, Israel, July 06, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty, clinical-stage pharmaceutical company focusing on the development of...
Easterseals Massachusetts Chooses CentralReach’s avail® Solution to Help Empower Individuals with Disabilities at Work and Home
29 juin 2022 11h03 HE
|
CentralReach
Fort Lauderdale, FL, June 29, 2022 (GLOBE NEWSWIRE) -- Easterseals Massachusetts is excited to announce it has selected CentralReach’s avail® solution to help support individuals with autism and...
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
29 juin 2022 08h30 HE
|
SciSparc Ltd
TEL AVIV, Israel, June 29, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty, clinical-stage pharmaceutical company focusing on the development of...
Hopebridge shares tips for a sensory-friendly Fourth of July
27 juin 2022 07h00 HE
|
Hopebridge
Indianapolis, IN, June 27, 2022 (GLOBE NEWSWIRE) -- Family, friends and community members can make Independence Day more enjoyable [KA1] for their loved ones with autism spectrum disorder (ASD) this...
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
23 juin 2022 09h30 HE
|
SciSparc Ltd
The Soroka University Ethics Committee Approval Received to Conduct a Clinical trial with SciSparc’s Proprietary SCI-210 Treatment TEL AVIV, Israel, June 23, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd....